Prinston Pharmaceutical Inc recalls Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical…
- Recall date
- May 30, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1049-2016
- FDA classification
- Class III
- Brand / firm
- Prinston Pharmaceutical Inc
- Sold / distributed
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare U.S., LLC, Cranbury, NJ 08512, NDC 43547-331-09.
Get recall alerts
Free email alert whenever Prinston Pharmaceutical Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Prinston Pharmaceutical Inc